Company: PIII
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001628280-25-026021
Chunk: 73

Company: P3 Health Partners Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 73
---
260 2,378 Net loss per share attributable to Class A common stockholders–basic$(6.28)$(7.86)Denominator–diluted:Weighted average Class A common shares outstanding–basic3,260 2,378 Weighted average effect of dilutive securities:Shares of Class V common stock— — Weighted average shares outstanding–diluted3,260 2,378 Net loss per share attributable to Class A common stockholders–diluted$(6.28)$(7.86)All periods presented in the table above have been retroactively adjusted to reflect the 1-for-50 reverse stock split effected on April 11, 2025. See Note 3 “Significant Accounting Policies” for further information.Shares of Class V common stock do not share in the earnings or losses of P3 and are therefore not participating securities. As such, separate presentation of basic and diluted net loss per share for Class V common stock under the two-class method is not required. The following table presents potentially dilutive securities excluded from the computation of 

P3 Health Partners Inc. | Q1 2025 Form 10-Q | 17

diluted net loss per share for the periods presented because their effect would have been anti-dilutive, adjusted for the reverse stock split as noted above.Three Months Ended March 31,20252024(in thousands)Stock warrants (1)6,3581,639Stock options (1)433111Restricted stock units (1)14193 Shares of Class V common stock (2)3,9193,930 Total10,8515,773__________________(1)Represents the number of instruments outstanding at the end of the period. Application of the treasury stock method would reduce this amount if they had a dilutive effect and were included in the computation of diluted net loss per share.(2)Shares of Class V common stock at the end of the period are considered antidilutive shares of Class A common stock under application of the if-converted method in 2024 and 2025.

Note 10: Redeemable Non-controlling InterestNon-controlling interest represents the portion of P3 LLC that the Company controls and consolidates but does not own (i.e., the Common Units held directly by equity holders other than the Company). The ownership of the Common Units is summarized as follows:March 31, 2025December 31, 2024Units (in thousands